Exclusive Interview: 42PLUS1 Winner DoMore Diagnostics
DoMore Diagnostics, the winner of the European 42plus1 pitch competition 2024, shares insights into their AI-driven cancer diagnostics technology and their exciting journey following recent funding success. We spoke with […]
Brown Gibbons Lang & Company Presents: DxPx U.S. at ADLM 2024
DxPx U.S. is an industry + investor partnering conference dedicated to Diagnostics, Digital Health, Precision Medicine, and Life Sciences Tools Chicago, IL — April 3, 2024 — Brown Gibbons Lang […]
